Notable Analyst Rating Changes 4/29: (ALXN) (WNS) (CE) Upgraded; (WYNN) (SRPT) (DB) Downgraded
Tweet Send to a Friend
UPGRADES
BMO Capital upgrades Alexion Pharmaceuticals (Nasdaq: ALXN) from Market Perform to Outperform and moves its price target from $165 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital upgrades Alexion Pharmaceuticals (Nasdaq: ALXN) from Market Perform to Outperform and moves its price target from $165 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
